Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use

New England Journal of Medicine

Volumn 336, Issue 15, 1997, Pages 1097-1100

  Katz, Mitchell H ^a,c   Gerberding, Julie Louise ^b  

^a S Francisco Dept of Public Health   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c AIDS Office San Francisco   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR; LAMIVUDINE; ZIDOVUDINE;

CHEMOPROPHYLAXIS; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INTRAVENOUS DRUG ABUSE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REVIEW; SEXUAL TRANSMISSION; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; DISEASE TRANSMISSION, HORIZONTAL; FEMALE; HEALTH POLICY; HIV INFECTIONS; HUMANS; MALE; PRIMARY PREVENTION; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES; ZIDOVUDINE;

EID: 0030948183     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199704103361512     Document Type: Review

References (41)

1. Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood - France, United Kingdom, and United States, January 1988-August 1994. MMWR Morb Mortal Wkly Rep 1995;44:929-33.
2. Gerberding JL. Prophylaxis for occupational exposure to HIV. Ann Intern Med 1996;125:497-501.
3. Update: provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV. MMWR Morb Mortal Wkly Rep 1996;45:468-80.
4. Carpenter CC, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1996: recommendations of an international panel. JAMA 1996;276:146-54.
5. DeGruttola V, Seage GR III, Mayer KH, Horsburgh CR Jr. Infectiousness of HIV between male homosexual partners. J Clin Epidemiol 1989; 42:849-56.
6. Wiley JA, Herschkorn SJ, Padian NS. Heterogeneity in the probability of HIV transmission per sexual contact the case of male-to-female transmission in penile-vaginal intercourse. Stat Med 1989;8:93-102.
7. Kaplan EH, Heimer R. A model-based estimate of HIV infectivity via needle sharing. J Acquir Immune Defic Syndr 1992;5:1116-8.
8. Downs AM, De Vincenzi I. Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:388-95.
9. Peterman TA, Stoneburner RL, Allen JR, Jaffe HW, Curran JW. Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion-associated infections. JAMA 1988;259:55-8. [Erratum, JAMA 1989;262:502.]
10. Lafon SW, Mooney BD, McMullen JP, et al. A double-blind, placebo-controlled study of the safety and efficacy of Retrovir (zidovudine) as a chemoprophylactic agent in health care workers exposed to HIV. In: Program and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, October 21-24, 1990. Washington, D.C.: American Society for Microbiology, 1990:167.
11. Voelker R. New HIV drugs cast in supporting roles. JAMA 1996;276: 585.
12. Royce RA, Seña A, Cates W Jr, Cohen MS. Sexual transmission of HIV. N Engl J Med 1997;336:1072-8.
13. Samuel MC, Mohr MS, Speed TP, Winkelstein W. Infectivity of HIV by anal and oral intercourse among homosexual men. In: Kaplan EH, Brandeau ML, eds. Modeling the AIDS epidemic: planning, policy, and prediction. New York: Raven Press, 1994:423-38.
14. Lifson AR, O'Malley PM, Hessol NA, Buchbinder SP, Cannon L, Rutherford GW. HIV seroconversion in two homosexual men after receptive oral intercourse with ejaculation: implications for counseling concerning safe sexual practices. Am J Public Health 1990;80:1509-11.
15. Rozenbaum W, Gharakhanian S, Cardon B, Duval E, Coulaud JP. HIV transmission by oral sex. Lancet 1988;1:1395.
16. Lane HC, Holmberg SD, Jaffe HW. HIV seroconversion and oral intercourse. Am J Public Health 1991;81:658.
17. Gaughwin MD, Gowans E, Ali R, Burrell C. Bloody needles: the volumes of blood transferred in simulations of needlestick injuries and shared use of syringes for injection of intravenous drugs. AIDS 1991;5: 1025-7.
18. Blauvelt A, Katz SI. The skin as target, vector, and effector organ in human immunodeficiency virus disease. J Invest Dermatol 1995;105: Suppl:122S-126S.
19. Pope M, Gezelter S, Gallo N, Hoffman L, Steinman RM. Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ T cells. J Exp Med 1995;182: 2045-56.
20. Clerici M, Levin JM, Kessler HA, et al. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. JAMA 1994;271:42-6.
21. Milman G, Sharma O. Mechanisms of HIV/SIV mucosal transmission. AIDS Res Hum Retroviruses 1994;10:1305-12.
22. Spira AI, Marx PA, Patterson BK, et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 1996;183:215-25.
23. Lu Y, Brosio P, Lafaile M, et al. Vaginal transmission of chimeric simian/human immunodeficiency viruses in rhesus macaques. J Virol 1996; 70:3045-50.
24. Miller CJ. Mucosal transmission of simian immunodeficiency virus. Curr Top Microbiol Immunol 1994;188:107-22.
25. Fahrner R, Beekmann SE, Koziol DE, Gerberding JL, Henderson DK. Safety of zidovudine (ZDV) administered as post-exposure prophylaxis to health care workers (HCW) sustaining HIV-related occupational exposures (OE). In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Fla., October 4-7, 1994. Washington, D.C.: American Society tor Microbiology, 1994:133.
26. Puro V, Ippolito G, Guzzanti E, et al. Zidovudine prophylaxis after accidental exposure to HIV: the Italian experience. AIDS 1992;6:963-9.
27. Tokars JI, Marcus R, Culver DH, et al. Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. Ann Intern Med 1993;118:913-9.
28. Sparrow MJ, Lavill K. Breakage and slippage of condoms in family planning clients. Contraception 1994;50:117-29.
29. Thompson JL, Yager TJ, Martin JL. Estimated condom failure and frequency of condom use among gay men. Am J Public Health 1993;83: 1409-13.
30. Technical guidance on HIV counseling. MMWR Morb Mortal Wkly Rep 1993;42(RR-2):11-7.
31. A physician guide to HIV prevention. Chicago: American Medical Association, 1996.
32. Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health 1996;86:642-54.
33. Albert J, Wahlberg J, Leitner T, Escanilla D, Uhlen M. Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes. J Virol 1994;68:5918-24.
34. Claydon E, Murphy S, Osborne EM, Kitchen V, Smith JR, Harris JR. Rape and HIV. Int J STD AIDS 1991;2:200-1.
35. Gostin LO, Lazzarini Z, Alexander D, Brandt AM, Mayer KH, Silverman DC. HIV testing, counseling, and prophylaxis after sexual assault. JAMA 1994;271:1436-44.
36. Foster I, Bartlett JG. Rape and subsequent seroconversion to HIV. BMJ 1989;299:1282.
37. Mathes LE, Polas PJ, Hayes KA, Swenson CL, Johnson S, Kociba GJ. Pre-and postexposure chemoprophylaxis: evidence that 3′-azido-3′-dideoxythymidine inhibits feline leukemia virus disease by a drug-induced vaccine response. Antimicrob Agents Chemother 1992;36:2715-21.
38. Martin LN, Murphey-Corb M, Soike KF, Davison-Fairburn B, Baskin GB. Effects of initiation of 3′-azido,3′-deoxythymidinc (zidovudine) treatment at different times after infection of rhesus monkeys with simian immunodeficiency virus. J Infect Dis 1993;168:825-35.
39. Hellinger FJ. The lifetime cost of treating a person with HIV. JAMA 1993;270:474-8.
40. Katz MH, Chang SW, Buchbinder SP, Hessol NA, O'Malley P, Doll LS. Health insurance and use of medical services by men infected with HIV. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:58-63.
41. Fleishman JA, Mor V. Insurance status among people with AIDS: relationships with sociodemographic characteristics and service use. Inquiry 1993;30:180-8.